-
公开(公告)号:US20240153229A1
公开(公告)日:2024-05-09
申请号:US18309903
申请日:2023-05-01
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , Mark A. BUCKLER , Vladimir VALTCHINOV , David S. PAIK
IPC: G06V10/25 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/00 , G06T7/11 , G06V10/764 , G06V20/69
CPC classification number: G06V10/25 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/0012 , G06T7/11 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20230386026A1
公开(公告)日:2023-11-30
申请号:US18319003
申请日:2023-05-17
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER
CPC classification number: G06T7/0012 , G06T7/11 , A61B6/504 , A61B8/0891 , A61B5/02007 , G06T2207/30101
Abstract: A system including a hierarchical analytics framework that can utilize a first set of machine learned algorithms to identify and quantify a set of biological properties utilizing medical imaging data is provided. System can segment the medical imaging data based on the quantified biological properties to delineate existence of perivascular adipose tissue. The system can also segment the medical imaging data based on the quantified biological properties to determine a lumen boundary and/or determine a cap thickness based on a minimum distance between the lumen boundary and LRNC regions.
-
公开(公告)号:US20230289939A1
公开(公告)日:2023-09-14
申请号:US18319053
申请日:2023-05-17
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Changguo JI , Murali AYYAPILLAI
CPC classification number: G06T5/50 , A61B6/482 , A61B6/4241 , A61B6/5247 , A61B6/504 , A61B6/463 , G06T7/0012 , G06T7/174 , G06T2207/20216 , G06T2207/10081 , G06T2207/10088 , G06T2207/10132 , G06T2207/20224
Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.
-
公开(公告)号:US20240161297A1
公开(公告)日:2024-05-16
申请号:US18545563
申请日:2023-12-19
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20240078671A1
公开(公告)日:2024-03-07
申请号:US18504795
申请日:2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/003 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20230326166A1
公开(公告)日:2023-10-12
申请号:US18307316
申请日:2023-04-26
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06V10/25 , G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/00 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/214 , G06V10/764
CPC classification number: G06V10/25 , G06T7/0012 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/003 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/2148 , G06V10/764 , G06T2207/10132 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10048 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20210282719A1
公开(公告)日:2021-09-16
申请号:US17328417
申请日:2021-05-24
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , Mark A. BUCKLER , Vladimir VALTCHINOV , David S. PAIK
IPC: A61B5/00 , G06T5/00 , G06T5/20 , G06T11/00 , G06T11/60 , A61B6/00 , G16H30/40 , G06N3/08 , G06T7/00 , A61B5/103 , G16H50/20 , G16H50/50 , G16H10/60 , A61B5/02
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20240078673A1
公开(公告)日:2024-03-07
申请号:US18504811
申请日:2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/003 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20240078672A1
公开(公告)日:2024-03-07
申请号:US18504802
申请日:2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/003 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号:US20230237759A1
公开(公告)日:2023-07-27
申请号:US18166284
申请日:2023-02-08
Applicant: ELUCID BIOIMAGING INC.
Inventor: Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , Mark A. BUCKLER , Vladimir VALTCHINOV , David S. PAIK
IPC: G06V10/25 , G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/00 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/214 , G06V10/764
CPC classification number: G06V10/25 , G06T7/0012 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/003 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/2148 , G06V10/764 , G06T2207/10132 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10048 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
-
-
-
-
-
-
-
-